Patents
Patents for C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975)
05/2008
05/02/2008WO2008049974A2 Peptide vaccine for influenza virus
05/02/2008WO2007061796A3 Pharmaceutical composition comprising high-potency sweetener
05/02/2008CA2703646A1 Peptide vaccine for influenza virus
05/01/2008US20080103295 Process for the preparation of sucrose-6-ester by esterification in the presence of solid superacid catalyst
05/01/2008US20080103104 Benzamide precursor with sulfur substituent; poly-ADP-ribose polymerase inhibitors, antitumor agents; leukemia, breast, ovarian, lung, bladder, prostate, pancreatic, and cervical cancers
04/2008
04/30/2008CN101168551A lousewort lignans compounds, preparation method and application thereof
04/29/2008US7365174 Azalide and azalactam derivatives and method for producing the same
04/29/2008US7365055 Derivatives of morphine-6-glucuronide, pharmaceutical compositions containing them, their preparation method and their uses
04/29/2008US7364787 Lysosphingolipid obtained by treating sphingolipid mixture with sphingolipid ceramide N-deacylase for use in improving medicines and enhancing cell and carbohydrate engineering
04/29/2008CA2268168C Carbohydrate purification using ultrafiltration, reverse osmosis and nanofiltration
04/29/2008CA2259203C Method for the synthesis of amines and amino acids with organoboron derivatives
04/24/2008WO2008047658A1 Animal feed additive and animal feed
04/24/2008WO2008047174A1 Alpha-galactosylceramide analogs, their methods of manufacture, intermediate compounds useful in these methods, and pharmaceutical compositions containing them
04/24/2008WO2008046463A1 Metal chelates having a perfluorinated peg group, method for the production thereof, and use thereof
04/24/2008US20080097085 Polyalcohol granulation which has reduced clumping during storage; sugar substitute
04/24/2008US20080096802 administering peroxisome proliferator-activated receptor agonists (PPAR) and sodium glucose co-transporters (SGLTs) inhibitors for the treatment of diabetes and Syndrome X
04/24/2008CA2666910A1 Metal chelates having a perfluorinated peg radical, processes for their preparation, and their use
04/24/2008CA2666781A1 .alpha.-galactoceramide analogs, their methods of manufacture, intermediate compounds useful in these methods, and pharmaceutical compositions containing them
04/23/2008EP1913948A1 Re-epithelializing pharmaceutical compositions containing xanthan gum
04/23/2008EP1649037A4 Immobilization of oligonucleotides and proteins in sugar-containing hydrogels
04/23/2008EP1513855B1 Fatty acid esters of ethoxylated alkylglucosides
04/23/2008EP1142591B1 Gene carriers
04/23/2008CN101165047A Glycolipid derivative and its manufacturing method, and its synthesizing intermediate and its manufacturing method
04/23/2008CN100382847C Ligand compound for image diagnosis and its preparing method and compound for image diagnosis and its intermediate preparation
04/22/2008US7361745 Process for the preparation of 1-chloro-3,5-di-o-acyl-2-deoxy-l-ribofuranoside derivatives
04/22/2008US7361744 Oligosaccharide derivative
04/22/2008US7361743 Lincomycin derivatives possessing antibacterial activity
04/22/2008US7361644 Glycomimetics linked to a benzyl amino sulfonic acid (BASA) and combined with another diagnostic or therapeutic agent; inhibition of tissue transplant rejection and cell adhesion
04/22/2008CA2129542C Pharmaceutical preparation based on rhamnolipid
04/17/2008WO2007084856A3 Method for purifying polysaccharides
04/16/2008EP1910390A2 Glucopyranosyl-substituted ((hetero)cycloalyklethynyl-benzyl)-benzene derivatives and use thereof as sodium-dependent glucose cotransporter (sglt) inhibitors
04/16/2008CN100381459C Adriamycin derivative and its preparing method and use
04/15/2008US7358346 Synthesis of C-beta-D-xylopyranoside-2-(S)-hydroxypropane or C-beta-D-fucopyranoside-2-(S)-hydroxypropane from C-beta-D-xylopyranoside-2-propanone or c-beta-D-fucopyranoside-2-propanone using sodium borohydride, isopropanol and sodium triacetoxyborohydride; glycosaminoglycans
04/15/2008US7358232 Using aqueous solution of water soluble antibiotic and surfactant; vaporizatio, evaportaion of water; forming deposits
04/15/2008US7357913 Methods for detecting, prognosing, or monitoring a disorder by comparing relative flux rates of two or more biological molecules in vivo
04/15/2008CA2328920C Novel derivatives of 3,3-diphenylpropylamines
04/10/2008US20080085838 Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
04/09/2008EP1907405A1 Thiocolchicoside analogues with myorelaxant and anti-inflammatory activity
04/09/2008CN101157711A Compound having antineoplastic activity and uses thereof
04/09/2008CN100379749C Method of preparing 4-R-substituted 4-demethoxydaunorubicin
04/08/2008US7355056 Transferring agent into cells; using polypeptides, polynucleotides, antibodies nucleic acids ; tumor suppressor gene; anticancer agents
04/03/2008WO2008037923A1 New derivatives of 5-thioxilopyranose
04/03/2008WO2007117500A3 Processes for chemical synthesis of lipochitooligosaccharides
04/03/2008CA2665908A1 New derivatives of 5-thioxilopyranose
04/03/2008CA2662309A1 Crystalline forms of valrubicin and processes for their preparation
04/02/2008EP1905766A1 Glycolipid derivative and therapeutic agent comprising the same as active ingredient
04/02/2008EP1716163B1 Method for the alkoxylation of alkyl and/or alkenyl polyglycosides
04/02/2008CN101152195A Application of aminoglycoside antibiotic in preparing pharmaceutical composition for treating drug-fast bacteria infection
04/01/2008US7351809 Glycerol carbonate glycoside
04/01/2008US7351807 Cyanine-sulfenates for dual phototherapy
04/01/2008US7351408 Glycoconjugates and methods
04/01/2008CA2363990C Use of glycyrrhizin in the treatment of mastitis
03/2008
03/27/2008WO2007128480A3 Thioglycosides as pharmaceutically active agents
03/27/2008WO2007070820A3 Method for preparing 4-demethyldaunorubicin
03/27/2008WO2007038829A8 Method of drug design
03/27/2008US20080076833 Phosphorylated Polyphenols as Colour-Stable Agents
03/27/2008US20080076137 Bioanalytic Systems and Methods
03/26/2008EP1903049A1 Crystalline forms of 1,6-Bis [3-(3-carboxymethylphenyl)-4-(2-alpha -D-mannopyranosyloxy)-phenyl] hexane
03/26/2008EP1902063A2 Derivatives of pentose monosaccharides as anti-inflammatory compounds
03/26/2008EP1409498B1 Inositol phosphoglycan derivatives and their medical uses
03/25/2008US7348309 glycosylating an aglycone by combining thymidine or uridine nucleotide diphosphosugars of given structure and a glycosyltransferase; generation of random nucleotide sugar libraries and drug derivatives; treating bacterial infection
03/25/2008CA2484638C Polyene polyketides and methods of production
03/20/2008WO2008032817A1 Sugar chain having activity against helicobacter pylori
03/20/2008US20080070851 Method for the extraction of pharmaceutically active products from spermatophyte plants, products thus obtained and their use in the medical field, in particular as substances with immunomodulating activity
03/20/2008US20080070850 Have a linker molecule that misaligns the carbohydrate cores; structurally simpler, easier to synthesize, and more potent; low toxicity; anticancer; 1,1'-O-2,2',3,3',4,4',6,6'-tetrakis(3,4,5-trihydroxybenzoyl)- beta , beta '-D,D'-glucopyranosylterephthalate
03/19/2008EP1900364A2 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
03/19/2008EP1899360A1 Compounds for the treatment of non-autoimmune type 2 diabetes mellitus and/or syndrome x
03/19/2008CN101146816A Glycolipids of branched chain alkyl oligosaccharides for liquid crystal and related applications
03/19/2008CN101143882A Tyrosinase activity cntrolling agent, process for producing the same and external preparations containing the same
03/18/2008CA2312762C Crystalline anthracycline antibiotic daunomycin hydrochloride and process for producing the same
03/13/2008WO2008030121A1 Sweetening compositions and processes for preparing them
03/13/2008WO2008030112A1 Processes of preparing asymmetric dinitrobenzamide mustard compounds, intermediate compounds useful therein and products obtained therefrom
03/13/2008WO2008028966A1 Crystalline forms of 1,6-bis [3-(3-carboxymethylphenyl)-4-(2-alpha-d-mannopyranosyl-oxy)-phenyl] hexane
03/13/2008WO2008028667A2 Use of glycolipids as adjuvants
03/13/2008WO2007091040A3 The preparation of thiosugars and their use
03/13/2008US20080064645 A carbohydrate linked to a fluorophore through a 2-amido-2-(1-hydroxyalkyl)ethoxy linkage; inhibition of caveolar endocytosis, plasma membrane microdomain formation, virus binding and infection, transmembrane signaling, and integrin function in cells; anticarcinogenic and antiinflammatory agents
03/13/2008CA2662831A1 Crystalline forms of 1,6-bis [3-(3-carboxymethylphenyl)-4-(2-.alpha.-d-mannopyranosyl-oxy)-phenyl] hexane
03/13/2008CA2661280A1 Mucosal and systemic adjuvants comprising glycolipids,corresponding conjugates and pharmaceutical compositions.
03/12/2008EP1897557A1 Use of glycolipids as adjuvants
03/12/2008EP1896045A2 Composition for the treatment and/or prevention of attacks by biological agents
03/12/2008CN101139375A Synthesis of 1-hydrocarbyl-2-(4-beta-D-pyrane allose glycosides-phenyl)-benzimidazole derivative
03/12/2008CN101139374A Method for extracting validamycin
03/12/2008CN101139373A Method for rapid scale extraction and purification of flax lignan
03/12/2008CN101138566A Prevention and treatment process for infectious diseases and other diseases by using immunity effect compounds
03/11/2008CA2290646C Triterpene saponin analogs having adjuvant and immunostimulatory activity
03/06/2008WO2008028060A2 Anti-tumor compounds for inhibiting cancer growth
03/05/2008EP1893623A1 C-glycoside compounds and use thereof for depigmenting the skin
03/05/2008EP1409501B1 Inositol phosphoglycan derivatives and their medical uses
03/05/2008CN100372862C Adriacin derivative with anti-cancer activity
03/05/2008CN100372861C Preparation method of alpha-arbutin
03/05/2008CN100372860C I*-salidroside and its preparation and use in anti-senile dimentia medicine
02/2008
02/28/2008US20080051341 Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or metabolic syndrome
02/28/2008DE10066210B4 Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Plaques Use of perfluoroalkyl-containing metal complexes as contrast agents in MR imaging for presentation of plaques
02/27/2008EP1891086A1 Method for the synthesis of anthocyanins
02/27/2008EP1891085A2 C-linked glucoronide of n-(4-hydroxybenzyl) retinone, analogs thereof, and method of using the same to inhibit neoplastic cell growth
02/27/2008CN101133075A Compounds for treating alzheimer's disease and for inhibiting beta-amyloid peptitde production
02/27/2008CN101130562A Method for preparing high purity validamycin powder agent
02/27/2008CN101130561A Method for producing salidroside and injection containing the same
02/27/2008CN101130560A Method for preparing rose cut flower flavouring agent and use method of flavouring agent
02/26/2008US7335627 Polymeric alkylpolyglycoside carboxylates
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 180